 |
인쇄하기
취소
|
Impending completion of merger between Genome Therapeutics and Genesoft Pharmaceuticals
The newly merged company between Genome Therapeutics (Nasdaq: GENE) and Genesoft Pharmaceuticals, a privately-held pharmaceutical company based in San Francisco of the United States, is set to launch on and about this March, market sources said recently.
The completion of the merger remains subject to various closing conditions, including the approval by both companies' shareholders. Genome ...
The completion of the merger remains subject to various closing conditions, including the approval by both companies' shareholders. Genome ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.